Press release
PKU Treatment Market 2022 Global Projection By Key Players - BASF SE Chr., Hansen, Cargill, Incorporated- Analysis and Forecast to 2031
PKU Treatment Market 2022PKU (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for PKU as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the symptoms mainly observed in such patients.
Get Free Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/14410
According to the latest report published by Persistence Market Research, the global PKU treatment market for protein ingredients was valued at US$ 325.9 Mn in 2019, and is predicted to witness an impressive CAGR of over 6% during the forecast period (2020-2030). Similarly, the market for finished products was valued at US$ 565.8 Mn in 2019, and is predicted to witness an impressive CAGR of around 7% through 2030.
Rising prevalence of PKU among newborns and surging demand for novel formulations to treat the disease have led to increased opportunities for market players. Stakeholders are investing more in research & development for novel treatment solutions within the nutraceutical industry.
Companies covered in PKU Treatment Market Report
Arla Foods Ingredients Group P/S
Archer Daniels Midland Company
BASF SE
Chr. Hansen
Cargill, Incorporated
Seidler Chemical Co, Inc.
Nestlé S.A. (Vitaflo International)
Reckitt Benckiser Group plc. (Mead Johnson & Company, LLC.)
Abbott Laboratories
APR Applied Pharma Research S. A.
Ajinomoto Co., Inc.
VitafriendsPKU
Pristine Organics Pvt. Ltd
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/14410
Key Takeaways from PKU Treatment Market Study
For Protein Ingredients
Essential and non-essential amino acid ingredients are expected to contribute more than 1/3 of the revenue share in the market.
Powder blend form is expected to gain traction in PKU treatment, accounting for more than 90% share throughout the forecast years.
By targeted customer, consumer healthcare companies hold the highest share of more than 80% in this space.
By sales channel, industry sales of protein ingredients are dominating the market.
North America holds the highest share in the global PKU treatment market, owing to the presence of big market players and growing research & development efforts in the region.
Key players are focused on expanding their product portfolios and expansion at regional levels through collaborations and acquisitions.
The market in the U.S. is projected to be the fastest-growing at a CAGR above 6.5% through 2030. The U.S. holds a big portion of the market revenue and accounts for more than 90% in North America.
For Finish Products
Essential and non-essential amino acids are expected to contribute more than 1/3 of the revenue share in the market.
The powder & granules form is expected to dominate PKU treatment, accounting for a share of more than 50% through 2030.
By targeted customer, adults account for the highest market share of more than 50%.
By sales channel, hypermarkets and supermarkets will hold the highest share throughout the forecast period.
North America holds more than 40% of the global PKU treatment market share.
Key market players are focusing on expansion of their product portfolios by highly investing in the research & development sector, and are generating high revenue through collaborations and acquisitions.
The market in the U.S. is projected to be the fastest-growing, and will expand at a CAGR close to 6% through 2030. The U.S. holds a big portion of the market revenue, and accounts for more than 90% share in North America.
"Increasing prevalence of PKU and rising adoption of PKU diets will upswing the global PKU treatment market over the coming years," says an analyst of Persistence Market Research.
Collaborations & Acquisitions Key Strategies amongst Market Players
Prominent players in the PKU treatment market are firming their product ranges through acquisitions and reaching out to emerging markets. Increasing investments and manufacturing capacity expansion are expected to favour growth of the global market over the forecast period.
For instance, Mead Johnson Nutrition Company was acquired by the Reckitt Benckiser Group plc (RB). Mead Johnson is now a division of RB, adding its globally-recognized brands, including Phenyl-Free® 1, an iron-fortified PKU infant formula and medical food powder for infants and young children with documented PKU.
Additionally, Abbott Laboratories collaborated with Syngene to inaugurate its first nutrition research & development centre in India.
Various players in the PKU treatment market are focusing on research & development, product launches, and advanced solutions to strengthen and expand their product portfolios.
For instance, Vitaflo USA introduced PKU Sphere™, a powdered, low phenylalanine medical food used in the dietary management of PKU . The medical food formula is a Glycomacropeptide (GMP)-based medical food containing a balanced mix of GMP and amino acids.
Ajinomoto Co., Inc. introduced a new product line, Glytactin BUILD 20/20™ and Glytactin RTD Lite, new PKU formulas featuring the next generation of Glytactin with 40% less Phe per gram of PE than all other GMP-based PKU medical foods.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the PKU treatment market in its latest study, presenting historical demand assessment of 2015 - 2019 and projections for 2020 - 2030. The research study is based on PKU ingredients (protein ingredient [Glycomacropeptide (GMP) and essential and non-essential amino acids] and finish products [Glycomacropeptide (GMP) and essential and non-essential amino acids]), targeted customer (protein ingredients [consumer healthcare companies, pharmaceutical companies, and contract manufacturing companies (CMOs)] and finish products [adults, paediatrics, and pregnant women]), form (protein ingredients [powder blend and granules], finish products [powder & granules, tablets, capsules, powder sachets, ready-to-drink, shakes, and other]), and sales channel (protein ingredients [industry sales], finish products [hospital pharmacies, retail pharmacies, online pharmacies, and hypermarkets & supermarkets]), across seven key regions of the world.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/14410
Key geographies evaluated in this report are:
North America - U.S, Canada
Europe - France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS
APAC - China, India, Japan, Australia, Others
Latin America - Argentina, Brazil, Others
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PKU Treatment Market 2022 Global Projection By Key Players - BASF SE Chr., Hansen, Cargill, Incorporated- Analysis and Forecast to 2031 here
News-ID: 2705678 • Views: …
More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…

Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…

Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…

Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for PKU
What foods can people eat with PKU? Industry Trends and Best Practices
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-07/what-do-the-8-wires-in-an-ethernet-cable-do-5.jpg
Phenylketonuria (PKU) is a rare inherited disorder that causes an amino acid called phenylalanine to build up in the body. PKU is caused by a change in the phenylalanine hydroxylase (PAH) gene, which helps create the enzyme needed to break down phenylalanine. Managing PKU means carefully controlling phenylalanine intake through diet.
A Founder's Heart: GuoHong Liu's Journey to SINOFN
Imagine a world where the very food you need to survive is…
More Than a Cake: SINOFN Launched PKU Health Care Activities
A Sweet Slice of Hope: SINOFN's Commitment to Children with PKU
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/weixin-image_2025-08-08_022524_697.jpg
For most families, a birthday cake is a simple joy. But for a child with Phenylketonuria (PKU), it represents a significant challenge. PKU is a rare inherited metabolic disorder where the body cannot process an amino acid called phenylalanine, found in most high-protein foods. A strict, lifelong low-protein diet is essential for their health and development.
This is a challenge…
PKU Market: Early Detection and New Therapies Fueling Future Expansion
The global PKU market is poised for significant growth in the coming years, driven by a rise in newborn screening programs, increasing awareness of the condition, and advancements in treatment options.
Market Overview
PKU is a rare genetic disorder affecting the body's ability to process the amino acid phenylalanine. If left untreated, it can lead to intellectual disability, seizures, and other neurological complications. Fortunately, early diagnosis and strict adherence to a special…
Phenylketonuria (PKU) Market Grow at Exceptional Rate By Top Emerging Key Player …
Phenylketonuria (PKU) Market Research Report
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Phenylketonuria (PKU) Industry Research Report, Growth Trends and Competitive Analysis 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Phenylketonuria (PKU)…
Global Phenylketonuria (PKU) Market Status and Outlook (2015-2025)
Market Overview
The Phenylketonuria (PKU) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Phenylketonuria (PKU) market size is expected to gain market growth in the forecast period of 2020 to…
Phenylketonuria (PKU) Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Phenylketonuria (PKU) market analysis, which studies the Phenylketonuria (PKU)'s industry coverage, current market competitive status, and market outlook and forecast by 2025.
Global “Phenylketonuria (PKU) Market 2020-2025” Research Report categorizes the global Phenylketonuria (PKU) market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth…